Header Logo

Cole Steven Hudson

TitlePostdoc Fellows and Associates
InstitutionBaylor College of Medicine
DepartmentPostDoc
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hudson CS, Teran NS, Tam VH, Hudson CS, Teran NS, Tam VH. Response to Yang et al. J Infect Dis. 2025 Sep 15; 232(3):e547-e548. PMID: 40179241.
      Citations:    Fields:    
    2. Hudson CS, Smith JE, Sun R, Vuong LT, Truong LD, Sheikh-Hamad D, Nigo M, Hu M, Tam VH. Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicity. Toxicol Appl Pharmacol. 2025 Sep 04; 505:117543. PMID: 40914503.
      Citations:    Fields:    
    3. Hudson CS, Xiao Y, Tam VH, Truong LD. Protection against vancomycin-associated nephrotoxicity by zileuton: role of mitochondria revealed by electron microscopic study. Ultrastruct Pathol. 2025; 49(5):414-420. PMID: 40762705.
      Citations:    Fields:    Translation:AnimalsCells
    4. Teran NS, Hudson CS, Phe K, Wang Y, Zhang Y, Chen H, Nigo M, Tam VH, Teran NS, Hudson CS, Phe K, Wang Y, Zhang Y, Chen H, Nigo M, Tam VH. Reduction of Vancomycin-Associated Acute Kidney Injury With Montelukast. J Infect Dis. 2025 Jul 30; 232(1):191-198. PMID: 39812174; PMCID: PMC12308645.
      Citations:    Fields:    Translation:Humans
    5. Hudson CS, Smith JE, Vuong LT, Teran NS, Pouya N, Sheikh-Hamad D, Liu X, Kajiji S, Tam VH. Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicity. Antimicrob Agents Chemother. 2025 08 06; 69(8):e0028725. PMID: 40626888; PMCID: PMC12326965.
      Citations:    Fields:    Translation:Animals
    6. Eales BM, Smith JE, Pouya N, Hudson CS, Baptista RP, Tran TT, Tam VH. Impact of iron limitation on in vitro and in vivo activity of ceftazidime against A. baumannii. Diagn Microbiol Infect Dis. 2025 Nov; 113(3):116991. PMID: 40651393.
      Citations:    Fields:    Translation:HumansAnimalsCells
    7. Eales BM, Smith J, Pouya N, Hudson CS, Tam VH, Nikolaou M. Rapid Design of Combination Antimicrobial Therapy against Acinetobacter baumannii. Comput Chem Eng. 2025 Jan; 192. PMID: 39781207; PMCID: PMC11709450.
      Citations:    
    8. Pouya N, Smith JE, Hudson CS, Teran NS, Tam VH, Pouya N, Smith JE, Hudson CS, Teran NS, Tam VH. In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2024 Sep; 38:252-255. PMID: 38996872; PMCID: PMC11742240.
      Citations:    Fields:    
    9. Hudson CS, Roy A, Li Q, Joshi AS, Yin T, Kumar A, Sheikh-Hamad D, Tam VH, Hudson CS, Roy A, Li Q, Joshi AS, Yin T, Kumar A, Sheikh-Hamad D, Tam VH. Mechanisms of gelofusine protection in an in vitro model of polymyxin B-associated renal injury. Am J Physiol Renal Physiol. 2024 Jul 01; 327(1):F137-F145. PMID: 38779756; PMCID: PMC12180518.
      Citations:    Fields:    Translation:AnimalsCells
    10. Hudson CS, Smith JE, Eales BM, Kajiji S, Liu X, Truong LD, Tam VH. Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model. J Antimicrob Chemother. 2023 10 03; 78(10):2435-2441. PMID: 37563789.
      Citations:    Fields:    Translation:HumansAnimals
    11. Hudson CS, Smith JE, Eales BM, Nikolaou M, Tam VH. In vitro model to simulate multiple drugs with distinct elimination half-lives. Int J Antimicrob Agents. 2023 Oct; 62(4):106924. PMID: 37433386; PMCID: PMC11344907.
      Citations:    Fields:    Translation:Humans
    12. Tam VH, Merlau PR, Hudson CS, Kline EG, Eales BM, Smith J, Sofjan AK, Shields RK. Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2022 10 28; 77(11):3130-3137. PMID: 36031868; PMCID: PMC10205629.
      Citations:    
    13. Tam VH, Hudson CS, Merlau PR, Shields RK. Hydrolytic activity of KPC-producing Klebsiella pneumoniae clinical isolates. J Chemother. 2022 09; 34(5):345-346. PMID: 34806561; PMCID: PMC9124231.
      Citations:    Fields:    
    14. Eales BM, Hudson CS, Kesisoglou I, Wang W, Nikolaou M, Tam VH. Experimental Validation of a Mathematical Framework to Simulate Antibiotics with Distinct Half-Lives Concurrently in an In Vitro Model. Antibiotics (Basel). 2021 Oct 16; 10(10). PMID: 34680836; PMCID: PMC8532833.
      Citations:    
    Hudson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (56)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _